ZBH Zimmer Biomet Loading... : Bullish and Bearish Analyst Opinions
From JNJ earnings callsLoading chart...
Top Calls
Feed
08:30
Jul 15
Jul 15
JNJ called out a modest cost-of-goods-sold tailwind from tariffs in medtech (offset other headwinds), implying some near-term tariff recoupment that may be incremental for the sector. — JNJ's ability to partially offset tariff costs through price or mix suggests a more resilient margin structure, contrasting with competitors who may not have similar leverage.
MED
About ZBH Analyst Coverage
Buzzberg tracks ZBH (Zimmer Biomet) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade idea tracked. Latest voices: Joe Wolk.